Attached files
file | filename |
---|---|
EX-10.1 - CardioGenics Holdings Inc. | v206332_ex10-1.htm |
UNITED
STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of
1934
Date
of report (Date of earliest event reported): December 22, 2010 (December
21, 2010)
CardioGenics Holdings
Inc.
(Exact
Name of Registrant as Specified in its Charter)
Nevada
|
000-28761
|
88-0380546
|
(State
or other jurisdiction of
incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification)
|
6295
Northam Drive, Unit 8, Mississauga, Ontario, L4V 1W8
(Address
of Principal Executive Offices)(Zip Code)
Registrant’s
telephone number, including area code: 905.673.8501
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General
Instruction A.2. below):
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
TABLE OF
CONTENTS
Item
1.01 Entry Into Material Definitive Agreement
|
Item 9.01
Exhibits
|
Item
1.01 – Entry Into Material Definitive Agreement
On March
23rd, 2010, CardioGenics Holdings Inc., a Nevada corporation (the “Company”) and Chandra
Panchal, a former director of the Company (the “Panchal”), entered
into a lock-up agreement (the “Lock-Up Agreement”)
pursuant to which Panchal agreed to lock-up until September 22, 2011 125,742
shares of the Company’s common stock owned by Panchal, in accordance with the
terms of the Lock-Up Agreement.
On
December 21, 2010 the Company and Panchal entered into a letter agreement
pursuant to which they agreed to terminate the Lock-Up Agreement, effective as
of the date of the letter agreement (the “Letter
Agreement”)
The
foregoing description of the Letter Agreement is qualified in its entirety by
reference to the full text of the Letter Agreement filed as Exhibit
10.1
Item
9.01 Exhibits.
Index
to Exhibits
10.1
|
Letter
Agreement dated December 21, 2010 entered into between CardioGenics
Holdings Inc. and Chandra Panchal
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
CARDIOGENICS
HOLDINGS INC.
|
||||
By:
|
/s/
Yahia Gawad
|
|||
Name:
|
Yahia
Gawad
|
|||
Title:
|
Chief
Executive Officer
|
Dated:
December 22, 2010